Analystreport

Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) had its "hold" rating re-affirmed by analysts at Jefferies Group LLC. They now have a $1.50 price target on the stock.

AEVI GENOMIC MEDICINE INC  (GNMX) 
Last aevi genomic medicine inc earnings: 11/14 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: aevigenomics.com